Literature DB >> 15380637

Type I collagen can function as a reservoir of basic fibroblast growth factor.

Akihiro Kanematsu1, Akira Marui, Shingo Yamamoto, Makoto Ozeki, Yoshiaki Hirano, Masaya Yamamoto, Osamu Ogawa, Masashi Komeda, Yasuhiko Tabata.   

Abstract

Storage and release of endogenous growth factors by the extracellular matrix (ECM) are important biological events that control tissue homeostasis and regeneration. The interaction between basic fibroblast growth factor (bFGF) and heparan sulfate proteoglycans has been extensively studied and used as a prototype model of such a system, while the lower affinity of fibrillar type I collagen for bFGF has generally been considered biologically insignificant. However, our present investigation revealed that bFGF spontaneously interacts with type I collagen solution and sponges under in vitro and in vivo physiological conditions, and is protected from the proteolytic environment by the collagen. bFGF incorporated in a collagen sponge sheet was sustainedly released in the mouse subcutis according to the biodegradation of the sponge matrix, and exhibited local angiogenic activity in a dose-dependent manner. Intramuscular injection of collagen microsponges incorporating bFGF induced a significant increase in the blood flow in the murine ischemic hindlimb, which could never have been attained by bolus injection of bFGF. These results suggest the significance and therapeutic utility of type I collagen as a reservoir of bFGF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380637     DOI: 10.1016/j.jconrel.2004.07.008

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  32 in total

1.  Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells.

Authors:  Akihiro Kanematsu; Shingo Yamamoto; Eri Iwai-Kanai; Isao Kanatani; Masaaki Imamura; Rosalyn M Adam; Yasuhiko Tabata; Osamu Ogawa
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

2.  Vascular growth factor binding kinetics to the endothelial cell basement membrane, with a kinetics-based correction for substrate binding.

Authors:  Alisa Morss Clyne; Elazer R Edelman
Journal:  Cytotechnology       Date:  2009-07-29       Impact factor: 2.058

Review 3.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.

Authors:  Marwa Tallawi; Elisabetta Rosellini; Niccoletta Barbani; Maria Grazia Cascone; Ranjana Rai; Guillaume Saint-Pierre; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

4.  A High-Throughput Workflow to Study Remodeling of Extracellular Matrix-Based Microtissues.

Authors:  Katherine A Cummins; Alexandra L Crampton; David K Wood
Journal:  Tissue Eng Part C Methods       Date:  2018-12-28       Impact factor: 3.056

5.  Heparin-functionalized collagen matrices with controlled release of basic fibroblast growth factor.

Authors:  J M Wu; Y Y Xu; Z H Li; X Y Yuan; P F Wang; X Z Zhang; Y Q Liu; J Guan; Y Guo; R X Li; H Zhang
Journal:  J Mater Sci Mater Med       Date:  2010-11-04       Impact factor: 3.896

6.  Binding and release characteristics of insulin-like growth factor-1 from a collagen-glycosaminoglycan scaffold.

Authors:  Leanne M Mullen; Serena M Best; Roger A Brooks; Siddhartha Ghose; Jessica H Gwynne; John Wardale; Neil Rushton; Ruth E Cameron
Journal:  Tissue Eng Part C Methods       Date:  2010-05-22       Impact factor: 3.056

7.  Secreted Frizzled-related protein 2 as a target in antifibrotic therapeutic intervention.

Authors:  Michalis Mastri; Zaeem Shah; Karin Hsieh; Xiaowen Wang; Bailey Wooldridge; Sean Martin; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

Review 8.  Tissue Engineering of the Microvasculature.

Authors:  Joe Tien
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 9.  Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis.

Authors:  Ana C Martins Cavaco; Sara Dâmaso; Sandra Casimiro; Luís Costa
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

10.  Micro- and Nanoparticles for Treating Cardiovascular Disease.

Authors:  S Suarez; A Almutairi; K L Christman
Journal:  Biomater Sci       Date:  2015-04       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.